[go: up one dir, main page]

WO1997030085B1 - Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese - Google Patents

Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese

Info

Publication number
WO1997030085B1
WO1997030085B1 PCT/US1997/002439 US9702439W WO9730085B1 WO 1997030085 B1 WO1997030085 B1 WO 1997030085B1 US 9702439 W US9702439 W US 9702439W WO 9730085 B1 WO9730085 B1 WO 9730085B1
Authority
WO
WIPO (PCT)
Prior art keywords
fact
troponin subunit
peptide
subunit
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/002439
Other languages
English (en)
Other versions
WO1997030085A1 (fr
Filing date
Publication date
Priority claimed from US08/602,941 external-priority patent/US5837680A/en
Application filed filed Critical
Priority to EP97905992A priority Critical patent/EP1007556B1/fr
Priority to AT97905992T priority patent/ATE266675T1/de
Priority to JP52953997A priority patent/JP3990456B2/ja
Priority to CA2247247A priority patent/CA2247247C/fr
Priority to AU22753/97A priority patent/AU707262B2/en
Priority to DE69729125T priority patent/DE69729125T2/de
Publication of WO1997030085A1 publication Critical patent/WO1997030085A1/fr
Publication of WO1997030085B1 publication Critical patent/WO1997030085B1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Abstract

Des procédés permettent d'inhiber l'angiogénèse atopique à l'aide de sous-unités de troponine et de leurs fragments peptidiques. On décrit aussi des compositions pharmaceutiques comprenant une sous-unité de troponine ou un de ses fragments. Ces compositions et procédés permettent de traiter des tumeurs solides, particulièrement celles du système nerveux central et de l'oeil.
PCT/US1997/002439 1996-02-16 1997-02-14 Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese Ceased WO1997030085A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP97905992A EP1007556B1 (fr) 1996-02-16 1997-02-14 Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
AT97905992T ATE266675T1 (de) 1996-02-16 1997-02-14 Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
JP52953997A JP3990456B2 (ja) 1996-02-16 1997-02-14 血管形成の阻害剤として有用なトロポニンのサブユニットおよびフラグメント
CA2247247A CA2247247C (fr) 1996-02-16 1997-02-14 Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
AU22753/97A AU707262B2 (en) 1996-02-16 1997-02-14 Troponin subunits and fragments useful as angiogenesis inhibitors
DE69729125T DE69729125T2 (de) 1996-02-16 1997-02-14 Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/602,941 US5837680A (en) 1996-02-16 1996-02-16 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US08/602,941 1996-02-16

Publications (2)

Publication Number Publication Date
WO1997030085A1 WO1997030085A1 (fr) 1997-08-21
WO1997030085B1 true WO1997030085B1 (fr) 1997-09-25

Family

ID=24413387

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/002439 Ceased WO1997030085A1 (fr) 1996-02-16 1997-02-14 Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese

Country Status (8)

Country Link
US (4) US5837680A (fr)
EP (1) EP1007556B1 (fr)
JP (1) JP3990456B2 (fr)
AT (1) ATE266675T1 (fr)
AU (1) AU707262B2 (fr)
CA (1) CA2247247C (fr)
DE (1) DE69729125T2 (fr)
WO (1) WO1997030085A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837680A (en) 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US6465431B1 (en) * 1999-11-17 2002-10-15 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
US6586401B1 (en) 1996-02-16 2003-07-01 Children's Medical Center Corporation Troponin subunit I fragment and homologs thereof
US6589936B1 (en) * 1996-02-16 2003-07-08 Children's Medical Center Corporation Pharmaceutical compositions comprising recombinant troponin subunits
US20030166065A1 (en) * 1997-04-24 2003-09-04 Human Genome Sciences, Inc. Novel integrin ligand ITGL-TSP
US7220557B2 (en) 1997-04-24 2007-05-22 Human Genome Sciences, Inc. METH1 polynucleotides
US6248869B1 (en) * 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
AU9673998A (en) * 1997-10-01 1999-04-23 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
KR100335397B1 (ko) * 1998-05-25 2002-09-05 주식회사 하이닉스반도체 센스앰프순차구동장치
ATE338119T1 (de) 1998-07-17 2006-09-15 Licentia Ltd Myotilin, ein actin-organisierendes protein
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
AU6117099A (en) * 1998-10-21 2000-05-08 Spectral Diagnostics Inc. Cardiac troponin i polypeptide fragments and uses in diagnostics
CA2367611A1 (fr) * 1999-03-15 2000-09-21 Richard M. Thorn Compositions pharmaceutiques renfermant des sous-unites de troponine, ou des fragments ou des homologues desdites sous-unites, et leur utilisation pour inhiber l'angiogenese
EP1187849A1 (fr) * 1999-05-25 2002-03-20 Human Genome Sciences, Inc. Polynucleotides et polypeptides meth1 et meth2
US20020142982A1 (en) * 1999-09-02 2002-10-03 Timothy Hla Method for regulating angiogenesis
EP2075582A3 (fr) 2000-07-12 2010-01-06 Agensys, Inc. Nouvel antigène de tumeur utile dans le diagnostic et la thérapie des cancers de la vessie, ovaire, poumon et rein
US20030236188A1 (en) * 2001-05-03 2003-12-25 Spytek Kimberly A. Novel human proteins, polynucleotides encoding them and methods of using the same
ATE471371T1 (de) * 2002-02-04 2010-07-15 Yoshida Hideo Antikrebsmittel mit verotoxinvarianten
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) * 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
ES2506142T3 (es) 2002-03-01 2014-10-13 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
JP2005528362A (ja) * 2002-03-21 2005-09-22 ユニヴァーシティ オヴ フロリダ 血管新生の調節法
US20060189519A1 (en) * 2002-09-26 2006-08-24 Karl Volz Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
EP2949658B1 (fr) 2003-03-03 2018-08-08 Dyax Corp. Peptides qui lient spécifiquement le récepteur HGF (CMET) et utilisations associées
CN1294987C (zh) * 2003-04-15 2007-01-17 刘凤鸣 心肌肌钙蛋白i在制备抑制肿瘤药物中的应用
CA2820537C (fr) 2003-04-23 2015-10-20 Valeritas, Inc. Pompe activee hydrauliquement pour l'administration de fluide
WO2006014425A1 (fr) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Procedes et dispositifs pour l'administration du glp-1 et leurs utilisations
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria
US20070130009A1 (en) * 2005-06-01 2007-06-07 Chad Steelberg System and method for media play pricing
WO2007067611A2 (fr) * 2005-12-07 2007-06-14 The Brigham And Women's Hospital, Inc. Méthodes pour traiter une maladie de reperfusion cardiaque
RU2438719C2 (ru) 2006-03-30 2012-01-10 ВАЛЕРИТАС Инк. Многокартриджное устройство для введения жидкости
US8468561B2 (en) 2006-08-09 2013-06-18 Google Inc. Preemptible station inventory

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512071B1 (fr) * 1990-01-25 1996-10-30 Children's Hospital Procede et compositions destines a inhiber l'angiogenese
FR2701954B1 (fr) * 1993-02-23 1995-07-07 Pasteur Sanofi Diagnostics Composition stabilisée de troponine pour immunoessais et procédé de stabilisation de troponine pour immunoessais.
US5837680A (en) 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis

Similar Documents

Publication Publication Date Title
WO1997030085B1 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
CA2247247A1 (fr) Sous-unites et fragments de troponine utiles comme inhibiteurs de l'angiogenese
Thomas et al. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity
CA2102429C (fr) Utilisation de facteurs de croissance osseuse et d'inhibiteurs de la resorption osseuse dans la stimulation de l'osteogenese
KR101029705B1 (ko) 신규 펩타이드 및 그 용도
CA2698766C (fr) Utilisation d'un polypeptide inhibiteur gastrique (pig) pour le traitement de troubles associes a un dysfonctionnement de la transmission synaptique
ATE342967T1 (de) Anti-invasive and anti-angiogene urokinase fragmente und deren verwendung
CA2596597A1 (fr) Procede pour la stimulation de synthese de collagene et/ou d'expression de facteur de croissance de keratinocytes (kgf)
US20200291095A1 (en) Method for promoting wound healing
US7053046B2 (en) Peptide activators of VEGF
US12186367B2 (en) Isoform Nell-1 peptide
CA2449284A1 (fr) Peptides d'alpha-fetoproteine et utilisations de ces derniers
EA037111B1 (ru) Способ лечения или предупреждения остеоартрита
WO2002058589A3 (fr) Agents et methodes favorisant la croissance osseuse
KR970701724A (ko) 스타니어스 단백질인 스타니오칼신의 소체(Corpuscles of stannius protein, stanniocalcin)
EP1644028A2 (fr) Substances a activite biologique du peptide intestinal vasoactif pour le traitement d'affections pulmonaires interstitielles
EP3442559B1 (fr) Peptides dérivés de bmp-7 pour l'utilisation dans le traitement ou la prévention de l'arthrose
DE602004001509T2 (de) Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung
US5595734A (en) Compositions comprising ONCONASE (tm) and lovastatin
KR20220150018A (ko) Zag 유래 펩타이드를 포함하는 흉터 및 켈로이드 개선용 조성물
US20240226233A1 (en) Composition comprising zag-derived peptide for improving scars and keloids
EP4631957A1 (fr) Peptide pour régénérer le cartilage et ses utilisations
CN120418267A (zh) 用于软骨再生的肽及其用途
CN120418266A (zh) 用于软骨再生的肽及其用途
KR20240086945A (ko) 연골 재생용 펩타이드 및 이의 용도